These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28165586)

  • 61. Apheresis of activated leukocytes with an immobilized polymyxin B filter in patients with septic shock.
    Kumagai T; Takeyama N; Yabuki T; Harada M; Miki Y; Kanou H; Inoue S; Nakagawa T; Noguchi H
    Shock; 2010 Nov; 34(5):461-6. PubMed ID: 20386499
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical Effects and Outcomes After Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Treatment for Septic Shock in Preterm Neonates.
    Nishizaki N; Hara T; Obinata K; Nakagawa M; Shimizu T
    Pediatr Crit Care Med; 2020 Feb; 21(2):156-163. PubMed ID: 31568052
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Postoperative polymyxin B hemoperfusion and mortality in patients with abdominal septic shock: a propensity-matched analysis.
    Iwagami M; Yasunaga H; Doi K; Horiguchi H; Fushimi K; Matsubara T; Yahagi N; Noiri E
    Crit Care Med; 2014 May; 42(5):1187-93. PubMed ID: 24365858
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hemoperfusion with polymyxin B-immobilized fiber attenuates the increased plasma levels of thrombomodulin and von Willebrand factor from patients with septic shock.
    Nakamura T; Suzuki Y; Shimada N; Ebihara I; Shoji H; Koide H
    Blood Purif; 1998; 16(4):179-86. PubMed ID: 9736787
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B-immobilized fiber.
    Ono S; Tsujimoto H; Matsumoto A; Ikuta S; Kinoshita M; Mochizuki H
    Am J Surg; 2004 Aug; 188(2):150-6. PubMed ID: 15249240
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of hemoperfusion with polymyxin B-immobilized fibre on serum neopterin and soluble interleukin-2 receptor concentrations in patients with septic shock.
    Nakamura T; Ebihara I; Shimada N; Suzuki S; Ushiyama C; Shoji H; Koide H
    J Infect; 1998 Nov; 37(3):241-7. PubMed ID: 9892527
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Endotoxin removal therapy with Polymyxin B immobilized fiber column: a single center experience from EUPHAS2 registry.
    Forin E; Lorenzoni G; Ferrer R; De Cal M; Zanella M; Marchionna N; Gregori D; Forfori F; Lorenzin A; Danzi V; Ronco C; De Rosa S
    Sci Rep; 2023 Oct; 13(1):17600. PubMed ID: 37845296
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial.
    Dellinger RP; Bagshaw SM; Antonelli M; Foster DM; Klein DJ; Marshall JC; Palevsky PM; Weisberg LS; Schorr CA; Trzeciak S; Walker PM;
    JAMA; 2018 Oct; 320(14):1455-1463. PubMed ID: 30304428
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Polymyxin B hemoperfusion as a feasible therapy after source control in abdominal septic shock.
    Kim JJ; Park YJ; Moon KY; Park JH; Jeong YK; Kim EY
    World J Gastrointest Surg; 2019 Dec; 11(12):422-432. PubMed ID: 31879534
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Changes in serum S100A12 and sRAGE associated with improvement of the PaO(2)/FiO(2) ratio following PMX-DHP therapy for postoperative septic shock.
    Takahashi G; Hoshikawa K; Matsumoto N; Shozushima T; Onodera C; Kan S; Akitomi S; Kikkawa T; Tomisawa Y; Kojika M; Sato N; Inoue Y; Suzuki K; Wakabayashi G; Endo S
    Eur Surg Res; 2011; 47(3):135-40. PubMed ID: 21921634
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber.
    Aoki H; Kodama M; Tani T; Hanasawa K
    Am J Surg; 1994 Apr; 167(4):412-7. PubMed ID: 8179086
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized controlled trial.
    Klein DJ; Foster D; Schorr CA; Kazempour K; Walker PM; Dellinger RP
    Trials; 2014 Jun; 15():218. PubMed ID: 24916483
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients.
    Sakamoto Y; Mashiko K; Matsumoto H; Hara Y; Kutsukata N; Yamamoto Y
    ASAIO J; 2007; 53(3):324-8. PubMed ID: 17515723
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Experience of direct hemoperfusion using polymyxin B-immobilized fiber on patients with endotoxin shock from urosepsis].
    Ushida H; Koizumi S; Johnin K; Katoh K; Okada Y
    Hinyokika Kiyo; 2001 May; 47(5):329-31. PubMed ID: 11433754
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Selection of hemoperfusion therapy for patients with septic shock on the basis of the primary disease.
    Kanno Y; Nemoto H; Nakamoto H; Okada H; Sugahara S; Nishidome K; Yamashita Y; Suzuki H
    J Artif Organs; 2003; 6(3):205-10. PubMed ID: 14598105
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Endotoxin adsorption by polymyxin B column or intraaortic balloon pumping use for severe septic cardiomyopathy.
    Nakamura K; Doi K; Inokuchi R; Fukuda T; Hiruma T; Ishii T; Nakajima S; Noiri E; Yahagi N
    Am J Emerg Med; 2013 May; 31(5):893.e1-3. PubMed ID: 23399331
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Polymyxin-B hemoperfusion and endotoxin removal: lessons from a review of the literature.
    Cruz DN; de Cal M; Piccinni P; Ronco C
    Contrib Nephrol; 2010; 167():77-82. PubMed ID: 20519901
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Polymyxin B hemoperfusion (PMX-F) for severe sepsis and septic shock].
    Hayashi Y
    Nihon Rinsho; 2012 Feb; 70(2):311-4. PubMed ID: 22413537
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Impact of polymyxin B hemoperfusion therapy on high endotoxin activity level patients after successful infection source control: a prospective cohort study.
    Lee WY; Kim HJ; Kim EY
    Sci Rep; 2021 Dec; 11(1):24132. PubMed ID: 34916567
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The effect of continuous veno-venous hemofiltration or direct hemoperfusion with polymyxin B-immobilized fiber on neutrophil respiratory oxidative burst in patients with sepsis and septic shock.
    Naka T; Shinozaki M; Akizawa T; Shima Y; Takaesu H; Nasu H
    Ther Apher Dial; 2006 Feb; 10(1):7-11. PubMed ID: 16556130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.